Comparing the real-world effects of once-weekly semaglutide and DPP-4is on cardiovascular outcomes, health care resource utilization, and medical costs in individuals with T2D and ASCVD
Adam de Havenon1; Xi Tan2; Yuanjie Liang2; Larisa Yedigarova2; Josh Noone2; Lin Xie2; Silvio E. Inzucchi3